George Yaghmour
Overview
Explore the profile of George Yaghmour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pyzer A, Dillon L, Sharon E, Karrison T, Zha Y, Fulton N, et al.
Blood Adv
. 2025 Feb;
PMID: 39928953
We conducted a multi-center, open-label, randomized phase II study to assess the efficacy of Nivolumab as maintenance therapy for patients with AML in first complete remission (CR) or CR with...
2.
Muhammad A, Ghazi E, Ali A, Tam E, Woan K, Chaudhary P, et al.
J Med Cases
. 2024 Sep;
15(10):261-266.
PMID: 39328803
Tyrosine kinase inhibitors (TKIs) have changed the prognosis of Philadelphia-positive B-cell acute lymphoblastic leukemia (ALL); however, relapsed and refractory disease after multiple TKIs continues to be a clinical challenge. Brexucabtagene...
3.
Ashouri K, Hom B, Ginosyan A, Rahimi Y, Resnick K, Nittur V, et al.
Br J Haematol
. 2024 Sep;
205(6):2234-2247.
PMID: 39295195
Philadelphia chromosome (Ph)-like acute lymphoblastic leukaemia (ALL) is a high-risk subtype with a gene expression profile similar to Ph-positive ALL, due to activation of tyrosine kinase signalling. To understand the...
4.
Al-Homsi A, DeFor T, Cole K, Cirrone F, King S, Suarez-Londono A, et al.
Transplant Cell Ther
. 2024 Aug;
30(11):1092-1098.
PMID: 39209024
Previously, we reported excellent results with the combination of post-transplant cyclophosphamide (PTCy), abatacept, and a short course of tacrolimus (CAST) for the prevention of graft-versus-host disease (GvHD) following peripheral blood...
5.
Ashouri K, Fernandez E, Ginosyan A, Feliciano C, Hom B, Rodman J, et al.
Transplant Proc
. 2024 Aug;
56(7):1671-1677.
PMID: 39174390
Background: The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft versus host disease (GVHD) for haploidentical allogeneic hematopoietic stem cell transplantation (allo-HSCT). There is limited data on...
6.
Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan A, et al.
EJHaem
. 2024 Apr;
5(2):423-427.
PMID: 38633126
No abstract available.
7.
Ashouri K, Ginosyan A, Chu M, Hom B, Hwang J, Resnick K, et al.
Leuk Res
. 2024 Apr;
141:107501.
PMID: 38631149
Background: Hematopoietic stem cell transplantation (HSCT) is a pivotal treatment for high-risk acute lymphocytic leukemia (ALL), although limited by suitable human leukocyte antigen (HLA)-matched sibling donors (MSD). This study evaluates...
8.
Cai Y, Ali A, Filler E, Bayati R, Toma T, Zaki O, et al.
Front Oncol
. 2024 Feb;
14:1329893.
PMID: 38410106
Graft-versus-host disease (GVHD) is a common complication in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is characterized as either acute or chronic based on symptomatology and histopathological findings....
9.
Ashouri K, Nittur V, Ginosyan A, Hwang J, Adnani B, Chen D, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Dec;
24(3):e59-e66.e2.
PMID: 38061959
Introduction: Detection of measurable residual disease (MRD) in adults with acute lymphoblastic leukemia (ALL) is a vital biomarker in risk prediction and treatment selection. Next-generation sequencing (NGS) offers greater sensitivity...
10.
Nazaretyan S, Ali A, Yaghmour G, Tong A, Castillo V, Rodrigues S, et al.
Respir Med Case Rep
. 2023 Oct;
46:101922.
PMID: 37841284
Background: Sweet Syndrome (SS) is a rare inflammatory skin condition characterized by the sudden appearance of tender, erythematous or violaceous papules, plaques, and nodules typically found on the face, neck,...